Which laboratory tests are used to detect chronic alcohol use or abuse?

Laboratory Tests for Detecting Chronic Alcohol Use

No single laboratory test is reliable for identifying alcohol use disorder; the best diagnostic strategy combines multiple biomarkers with validated screening questionnaires like AUDIT, rather than relying on labs alone. 1

Recommended Testing Approach

First-Line Screening Tools

• Validated questionnaires (AUDIT, AUDIT-C) should be the primary screening method in all clinical settings, as they effectively identify heavy users and predict long-term outcomes better than laboratory tests alone 1
• All patients in primary care, gastroenterology clinics, emergency departments, and inpatient settings should undergo routine alcohol screening with these questionnaires 1

Direct Biomarkers (Most Specific and Sensitive)

Phosphatidylethanol (PEth) is the preferred biomarker for chronic alcohol use:

• Sensitivity of 91-100% and specificity of 77-96% for detecting heavy drinking 1
• Half-life of 10-14 days, unaffected by liver disease, kidney disease, age, BMI, or sex 1
• Cutoff of 80 ng/mL detects ≥4 drinks/day; cutoff of 20 ng/mL has higher sensitivity 1
• Women may have higher PEth levels for equivalent alcohol consumption 1

Urinary Ethyl Glucuronide (EtG) and Ethyl Sulfate (EtS) for recent use:

• Sensitivity of 76-89% and specificity of 86-99% for detecting alcohol use within 3 days 1
• EtG detectable in urine from 6 hours up to 100 hours after intake 2
• Not affected by liver disease, making them preferable in patients with hepatic dysfunction 1
• Detection window prolonged in renal failure 1

Indirect Biomarkers (Less Specific, More Readily Available)

Gamma-Glutamyl Transferase (GGT):

• Elevated in approximately 75% of patients drinking >60 g/day of ethanol for ≥5 weeks 2
• Higher sensitivity than AST but not specific for alcohol use 1
• Useful for monitoring abstinence during treatment; levels decrease by ~19% after 12 weeks of abstinence 3
• Area under curve (AUC) of 0.68 for detecting excessive drinking 3

Carbohydrate-Deficient Transferrin (%CDT):

• Most specific traditional marker with AUC of 0.77 3
• Elevated after 60-80 g/day of alcohol for minimum 2 weeks 2
• Half-life of 2-3 weeks; normalizes with abstinence in 2-3 weeks 1, 2
• Major limitation: Low sensitivity of only 25-50% in most studies 1
• False positives occur in severe liver disease without alcohol use 1
• More accurate post-transplant due to improved liver function 1
• Levels decrease by ~43% after 12 weeks of abstinence 3

Mean Corpuscular Volume (MCV):

• Dose-dependent correlation with alcohol consumption 2
• Decreases by only ~2.7% after 12 weeks of abstinence, making it less useful for monitoring 3
• Lacks sensitivity and specificity for timely detection 4

AST and ALT:

• Frequently elevated 2-4 times above normal in alcohol use disorder 2
• AST/ALT ratio >2 is NOT indicative of alcohol use alone - only 2% of excessive drinkers have this ratio 3
• AST/ALT ratio >2 is highly suggestive of alcoholic cirrhosis, with 51% of cirrhotic patients showing this pattern 3
• These enzymes remain unchanged during early abstinence, limiting their utility for monitoring 3

Optimal Testing Strategy

For initial screening and diagnosis:

• Combine %CDT with GGT using a mathematically formulated equation to achieve high sensitivity without losing specificity 5
• Add PEth testing when available for superior accuracy unaffected by liver disease 1

For monitoring abstinence:

• GGT and %CDT are most useful for chronic abstinence monitoring 2
• PEth provides objective evidence over 10-14 day window 1

For detecting recent/acute use:

• Blood alcohol concentration and urinary EtG are most valuable 2
• Urinary EtG and EtS preferred in patients with liver disease 1

Critical Pitfalls to Avoid

• Never use biomarkers alone to confirm or refute alcohol use; always combine with clinical interview, physical exam, and other testing 1
• Discuss biomarker testing with patients beforehand to maintain therapeutic alliance and improve disclosure 1
• Do not interpret AST/ALT ratio >2 as evidence of alcohol use in the absence of cirrhosis - this is a common misinterpretation 3
• Avoid relying on indirect markers (GGT, MCV, liver enzymes) alone as they lack adequate sensitivity and specificity 4
• Remember that %CDT has poor sensitivity despite good specificity, missing 50-75% of excessive drinkers 1, 3